Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | microtubule associated protein 2 | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Echinococcus multilocularis | microtubule associated protein 2 | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Schistosoma mansoni | microtubule-associated protein tau | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Schistosoma japonicum | ko:K04380 microtubule-associated protein tau, putative | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.116 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.015 | 0.0045 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0106 | 0.0126 |
Loa Loa (eye worm) | hypothetical protein | 0.0665 | 0.5567 | 0.5519 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0106 | 0.0126 |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0665 | 0.5567 | 0.5519 |
Brugia malayi | LBP / BPI / CETP family, N-terminal domain containing protein | 0.116 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0665 | 0.5567 | 0.5519 |
Loa Loa (eye worm) | hypothetical protein | 0.0495 | 0.4044 | 0.3981 |
Onchocerca volvulus | 0.0665 | 0.5567 | 0.2556 | |
Loa Loa (eye worm) | hypothetical protein | 0.0665 | 0.5567 | 0.5519 |
Brugia malayi | hypothetical protein | 0.0495 | 0.4044 | 0.4044 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0833 | 0.7074 | 1 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 0.7074 | 0.8441 |
Brugia malayi | LBP/BPI | 0.0495 | 0.4044 | 0.4044 |
Onchocerca volvulus | 0.116 | 1 | 1 | |
Brugia malayi | hypothetical protein | 0.0665 | 0.5567 | 0.5567 |
Loa Loa (eye worm) | hypothetical protein | 0.0495 | 0.4044 | 0.3981 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0665 | 0.5567 | 0.5567 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.015 | 0.015 |
Onchocerca volvulus | 0.116 | 1 | 1 | |
Onchocerca volvulus | 0.116 | 1 | 1 | |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0665 | 0.5567 | 0.5567 |
Onchocerca volvulus | 0.0665 | 0.5567 | 0.2556 | |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0 | 0.5 |
Onchocerca volvulus | 0.116 | 1 | 1 | |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.015 | 0.0045 |
Loa Loa (eye worm) | hypothetical protein | 0.0665 | 0.5567 | 0.5519 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 0.7074 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0106 | 0.0149 |
Loa Loa (eye worm) | hypothetical protein | 0.0495 | 0.4044 | 0.3981 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0106 | 0.0149 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0106 | 0.0149 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0106 | 0.0149 |
Loa Loa (eye worm) | hypothetical protein | 0.0495 | 0.4044 | 0.3981 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0495 | 0.4044 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0106 | 0.0149 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0665 | 0.5567 | 0.5567 |
Loa Loa (eye worm) | hypothetical protein | 0.0665 | 0.5567 | 0.5519 |
Loa Loa (eye worm) | hypothetical protein | 0.116 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0 | 0.5 |
Onchocerca volvulus | 0.116 | 1 | 1 | |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.116 | 1 | 1 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.116 | 1 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0106 | 0.0106 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.015 | 0.015 |
Onchocerca volvulus | 0.116 | 1 | 1 | |
Onchocerca volvulus | 0.116 | 1 | 1 | |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0979 | 0.8381 | 1 |
Brugia malayi | hypothetical protein | 0.0665 | 0.5567 | 0.5567 |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0665 | 0.5567 | 0.5519 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.